GlassScriptPhysician profile
James H Neel
NPI 1942408620
$6,551.94
in general payments reported to CMS, 2019-2025
17 companies · $1,019 in 2025
The $1,019 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,098 · 2021: $1,387 · 2022: $884 · 2023: $774 · 2024: $1,389 · 2025: $1,019.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,972 · Travel and Lodging: $211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,971.84 |
| Travel and Lodging | $210.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $2,520.47 | 2021-2025 | Impella |
| Edwards Lifesciences Corporation | $1,342.10 | 2021-2024 | Inspiris Resilia Aortic Valve |
| Intuitive Surgical, INC. | $1,293.59 | 2019-2024 | Da Vinci Surgical System |
| Abbott Laboratories | $454.96 | 2022-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, Amplatzer Amulet |
| Atricure, INC. | $429.88 | 2023-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Baxter Healthcare | $138.42 | 2023-2025 | Preveleak |
| W. L. Gore & Associates, INC. | $84.59 | 2019-2025 | Gore Tag Conformable Thoracic Endoprosthesis |
| Depuy Synthes Sales INC. | $61.01 | 2022-2025 | |
| Bolton Medical INC | $41.39 | 2024 | Treo Abdominal Stent-Graft System |
| Nalu Medical, INC. | $38.59 | 2025 | Nalu Neurostimulation System |
| Surmodics, INC. | $26.94 | 2025 | Pounce Venous Thrombectomy System, Pounce Thrombectomy, Sublime Microcatheter, 018, 200cm, Straight |
| Janssen Pharmaceuticals, INC | $26.89 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $23.69 | 2021 | |
| Medtronic, INC. | $22.88 | 2023 | Endurant Iis |
| Octapharma USA, INC. | $17.76 | 2025 | Fibryga |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $15.51 | 2023 | |
| Biomerieux INC | $13.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Neel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.